NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer (Q59138821)
Jump to navigation
Jump to search
scientific article published on 28 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer |
scientific article published on 28 March 2014 |
Statements
NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer (English)
D Thomson
H Yang
H Baines
E Miles